GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (XCNQ:VEXT) » Definitions » Deferred Tax

Vext Science (XCNQ:VEXT) Deferred Tax : C$-0.16 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Vext Science's change in deferred tax for the three months ended in Sep. 2024 was C$-0.32 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.16 Mil.

Vext Science Deferred Tax Historical Data

The historical data trend for Vext Science's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science Deferred Tax Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial 1.15 0.66 2.35 -5.73 -4.06

Vext Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.06 0.98 -0.47 -0.35 -0.32

Vext Science Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.16 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science Deferred Tax Related Terms

Thank you for viewing the detailed overview of Vext Science's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Vext Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (XCNQ:VEXT) » Definitions » Deferred Tax
Comparable Companies
XCNQ:BZAM XCNQ:RWB XCNQ:LEEF XCNQ:GWAY XCNQ:TRIP NEOE:FH TSXV:ROMJ XCNQ:BNXT XCNQ:CNTR XCNQ:RIV ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
VEXTF:USA VV5:Germany
Address
4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Website
https://www.vextscience.com
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.
Executives
Caroline Marie-clothilde Williams Director

Vext Science Headlines

No Headlines